期刊
NATURE REVIEWS CANCER
卷 12, 期 10, 页码 671-684出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3322
关键词
-
类别
资金
- National Institutes of Health, Center for Regenerative Medicine (NIH-CRM)
- Center for Cancer Research (CCR) by the US National Cancer Institute (Bethesda, Maryland)
Stem cells are defined by the ability to self-renew and to generate differentiated progeny, qualities that are maintained by evolutionarily conserved pathways that can lead to cancer when deregulated. There is now evidence that these stem cell-like attributes and signalling pathways are also shared among subsets of mature memory T lymphocytes. We discuss how using stem cell-like T cells can overcome the limitations of current adoptive T cell therapies, including inefficient T cell engraftment, persistence and ability to mediate prolonged immune attack. Conferring stemness to antitumour T cells might unleash the full potential of cellular therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据